GeneTex Develops Recombinant Influenza Nucleoprotein Antibodies as Potential Diagnostics

IRVINE, Calif.: IRVINE, Calif., Aug. 2, 2021 /PRNewswire/ -- GeneTex, a leading international antibody manufacturer, has established a reputation for providing highly validated research antibodies to virologists with extensive antibody portfolios for SARS-CoV-2, Zika virus, Dengue virus, and other viral pathogens. The Company has now expanded its existing influenza virus...

Click to view original post